The board of directors of Shanghai Pharmaceuticals Holding Co. Ltd. announced that the principal place of business of the Company in Hong Kong has been changed to 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong with effect from 20 February 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.92 CNY | -0.78% | +0.67% | +7.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.11% | 8.21B | |
+13.42% | 69.68B | |
-1.28% | 25.05B | |
-20.55% | 7.96B | |
-4.06% | 7.75B | |
+1.77% | 4.64B | |
+17.12% | 4.32B | |
-1.24% | 4.09B | |
-2.96% | 3.82B | |
+21.42% | 3.62B |
- Stock Market
- Equities
- 601607 Stock
- News Shanghai Pharmaceuticals Holding Co., Ltd
- Shanghai Pharmaceuticals Holding Co., Ltd Announces Change of Principal Place of Business in Hong Kong